NCT04934774 - Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2023

Conditions

T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaT-cell Non-Hodgkin Lymphoma

Interventions

BIOLOGICAL

CD7 CAR T cells

Non-gene edited anti-CD7 CAR T cells administered to patients, will be either fresh or thawed CAR T cells by IV injection after receiving lymphodepleting chemotherapy.

Trial Locations (1)

Unknown

RECRUITING

Peking University Shenzhen Hospital, Shenzhen